Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line
Cancer Science · 2024
DOI: 10.1111/cas.16162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Thao Nguyen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Gene Editing, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
In childhood acute lymphoblastic leukemia (ALL), TP53 gene mutation is associated with chemoresistance in a certain population of relapsed cases. To directly verify the association of TP53 gene mutation with chemoresistance of relapsed childhood ALL cases and improve their prognosis, the development of appropriate human leukemia models having TP53 mutation in the intrinsic gene is required. Here, we sought to introduce R248Q hotspot mutation into the intrinsic TP53 gene in an ALL cell line, 697, by applying a prime editing (PE) system, which is a versatile genome editing technology. The PE2 system uses an artificial fusion of nickase Cas9 and reverse‐transcriptase to directly place new genetic information into a target site through a reverse transcriptase template in the prime editing guide RNA (pegRNA). Moreover, in the advanced PE3b system, single guide RNA (sgRNA) matching the edited sequence is also introduced to improve editing efficiency. The initially obtained MDM2 inhibitor‐resistant PE3b‐transfected subline revealed disrupted p53 transactivation activity, reduced p53 target gene expression, and acquired resistance to chemotherapeutic agents and irradiation. Although the majority of the subline acquired the designed R248Q and adjacent silent mutations, the insertion of the palindromic sequence in the scaffold hairpin structure of pegRNA and the overlap of the original genomic DNA sequence were frequently observed. Targeted next‐generation sequencing reconfirmed frequent edit errors in both PE2 and PE3b‐transfected 697 cells, and it revealed frequent successful edits in HEK293T cells. These observations suggest a requirement for further modification of the PE2 and PE3b systems for accurate editing in leukemic cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
- McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Department of Advanced Diagnosis, Clinical Research Center, NHO Nagoya Medical Center, Nagoya, Japan.
- Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Higashihiroshima, Japan.
ORCID-Profile: Thao Nguyen, Koshi Akahane
Förderung
- JSPS
- Japan Society for the Promotion of Science
Zitieren
APA
Nguyen, T., Aida, T., Iijima-Yamashita, Y., Tamai, M., Nagamachi, A., Kagami, K., Komatsu, C., Kasai, S., Akahane, K., Goi, K., Inaba, T., Sanada, M., & Inukai, T. (2024). Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line. Cancer Science. https://doi.org/10.1111/cas.16162
Vancouver
Nguyen T, Aida T, Iijima-Yamashita Y, Tamai M, Nagamachi A, Kagami K, et al. Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line. Cancer Science. 2024. doi:10.1111/cas.16162
BibTeX
@article{Nguyen2024,
author = {Nguyen, Thao and Aida, Tomomi and Iijima-Yamashita, Yuka and Tamai, Minori and Nagamachi, Akiko and Kagami, Keiko and Komatsu, Chiaki and Kasai, Shin and Akahane, Koshi and Goi, Kumiko and Inaba, Toshiya and Sanada, Masashi and Inukai, Takeshi},
title = {Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16162}
}
EUVIMED